26 results on '"Jordan, Emmet"'
Search Results
2. Frequency of next-generation sequencing, prevalence of targetable mutations and response to targeted therapies amongst patients with metastatic urothelial cancer in Ireland: a multi-centre retrospective study of real-world data
3. miRNAs as biomarkers of therapeutic response to HER2-targeted treatment in breast cancer: A systematic review
4. The prognostic value of the derived neutrophil-to-lymphocyte ratio (dNLR) in patients treated with immune checkpoint inhibitors
5. Pregnancy-associated breast cancer: evaluating maternal and foetal outcomes. A national study
6. Frequency of next-generation sequencing, prevalence of targetable mutations and response to targeted therapies amongst patients with metastatic urothelial cancer in Ireland: a multi-centre retrospective study of real-world data.
7. Clinical and Genomic Characterization of Bladder Carcinomas With Glandular Phenotype
8. YES1 amplification is a mechanism of acquired resistance to EGFR inhibitors identified by transposon mutagenesis and clinical genomics
9. Obesity and cardiovascular risk in an oncology day ward population
10. Tumor mutational load predicts survival after immunotherapy across multiple cancer types
11. Targeted Therapy in Advanced Bladder Cancer: What Have We Learned?
12. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
13. MUTATIONAL LANDSCAPE OF PRIMARY BLADDER AND URACHAL ADENOCARCINOMA: MP88-13
14. Acanthosis Nigricans in a Patient with Urothelial Carcinoma Treated with PD-L1 Inhibitor Avelumab, and Secondary Adrenal Insufficiency.
15. MP72-20 PLASMACYTOID VARIANT OF UROTHELIAL CARCINOMA IS ASSOCIATED WITH E-CADHERIN LOSS
16. Second-line chemotherapy in advanced biliary cancers: A retrospective, multicenter analysis of outcomes.
17. Frequency and outcomes of brain metastases in patients with HER2-mutant lung cancers.
18. Obesity and cardiovascular risk in an oncology day ward population.
19. Harnessing Clinical Sequencing Data for Survival Stratification of Patients With Metastatic Lung Adenocarcinomas.
20. Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic Neoplasms.
21. YES1 amplification is a mechanism of acquired resistance to EGFR inhibitors identified by transposon mutagenesis and clinical genomics.
22. Brain Metastases in Pancreatic Ductal Adenocarcinoma: Assessment of Molecular Genotype-Phenotype Features-An Entity With an Increasing Incidence?
23. Systemic anti-cancer therapy in older patients with gastrointestinal malignancies following comprehensive geriatric assessment: An age-based subgroup analysis.
24. Clinical and Molecular Analysis of Adenosquamous Carcinoma of the Pancreas.
25. MP88-13 MUTATIONAL LANDSCAPE OF PRIMARY BLADDER AND URACHAL ADENOCARCINOMA.
26. Urachal Carcinoma Shares Genomic Alterations with Colorectal Carcinoma and May Respond to Epidermal Growth Factor Inhibition.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.